Experts Extol Combination Therapies as Future of Alzheimer’s Treatment

October 06, 2022

While promising data from Biogen and Eisai’s lecanemab breathed new life into the anti-amyloid approach last week, Alzheimer’s disease is complex enough that combination therapies will likely play a significant role in future symptomatic treatments.

A combination of medications has proven effective in treating multiple diseases, such as cancer and diabetes. Could the same be true for AD?

Sharon Rogers, Ph.D., chief executive officer of AmyriAD Therapeutics, believes treatments targeting the multiple symptoms of the disease will provide a benefit for patients receiving the standard-of-care treatment Aricept (donepezil).

Read the full article here.